Results
|
|
1041.
|
|
|
|
1042.
|
|
|
|
1043.
|
|
|
|
1044.
|
|
|
|
1045.
|
|
|
|
1046.
|
|
|
|
1047.
|
|
|
|
1048.
|
|
|
|
1049.
|
|
|
|
1050.
|
Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOW. [electronic resource] by
- Tripathy, Devjit
- Schwenke, Dawn C
- Banerji, MaryAnn
- Bray, George A
- Buchanan, Thomas A
- Clement, Stephen C
- Henry, Robert R
- Kitabchi, Abbas E
- Mudaliar, Sunder
- Ratner, Robert E
- Stentz, Frankie B
- Musi, Nicolas
- Reaven, Peter D
- DeFronzo, Ralph A
Producer: 20170608
In:
The Journal of clinical endocrinology and metabolism vol. 101
Availability: No items available.
|
|
|
1051.
|
|
|
|
1052.
|
|
|
|
1053.
|
|
|
|
1054.
|
|
|
|
1055.
|
Pioglitazone (AD-4833) ameliorates insulin resistance in patients with NIDDM. AD-4833 Glucose Clamp Study Group, Japan. [electronic resource] by
- Yamasaki, Y
- Kawamori, R
- Wasada, T
- Sato, A
- Omori, Y
- Eguchi, H
- Tominaga, M
- Sasaki, H
- Ikeda, M
- Kubota, M
- Ishida, Y
- Hozumi, T
- Baba, S
- Uehara, M
- Shichiri, M
- Kaneko, T
Producer: 19980707
In:
The Tohoku journal of experimental medicine vol. 183
Availability: No items available.
|
|
|
1056.
|
|
|
|
1057.
|
|
|
|
1058.
|
|
|
|
1059.
|
|
|
|
1060.
|
|